AbbVie
ABBV
ABBV
3,901 hedge funds and large institutions have $294B invested in AbbVie in 2025 Q3 according to their latest regulatory filings, with 293 funds opening new positions, 1,656 increasing their positions, 1,469 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more repeat investments, than reductions
Existing positions increased: 1,656 | Existing positions reduced: 1,469
3% more funds holding
Funds holding: 3,775 → 3,901 (+126)
1.13% less ownership
Funds ownership: 73.11% → 71.98% (-1.1%)
Holders
3,901
Holding in Top 10
215
Calls
$4.29B
Puts
$3.71B
Top Buyers
| 1 | +$1.76B | |
| 2 | +$361M | |
| 3 | +$358M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$314M |
| 5 |
Amundi
Paris,
France
|
+$288M |
Top Sellers
| 1 | -$600M | |
| 2 | -$497M | |
| 3 | -$412M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$373M |
| 5 |
BlackRock
New York
|
-$301M |